Hepatitis C virus infection in haemodialysis: The 'no-isolation' policy should not be generalized

Nephron - Clinical Practice

Volumn 111, Issue 2, 2009, Pages

  Agarwal, Sanjay Kumar ^a   Dash, Suresh Chand ^a   Gupta, Sanjay ^a   Pandey, Ravinder Mohan ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Haemodialysis; HCV; Isolation

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN;

ACUTE KIDNEY FAILURE; ADOLESCENT; ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD TRANSFUSION; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH CARE POLICY; HEMODIALYSIS; HEPATITIS C; HUMAN; HUMAN TISSUE; INFECTION CONTROL; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LABORATORY TEST; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; SCREENING; SEROCONVERSION; TIME SERIES ANALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; KIDNEY FAILURE, CHRONIC; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PATIENT ISOLATION; RENAL DIALYSIS; YOUNG ADULT;

EID: 58149489475     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000191208     Document Type: Article

References (40)

1. Sumathy S, Valliammai T, Thiyagrajan SP, Malathy S, Madangopalan N, Sankaranaraynan V, et al: Prevalence of hepatitis C virus infection in liver disease, renal disease and voluntary blood donors in South India. Ind J Med Microbiol 1993;11:291-297.
2. Arankale VA, Chadha MS, Jha J, Amrapurkar DN, Banerjee K: Prevalence of anti HCV antibodies in Western India. Ind J Med Res 1995;101:91-93.
3. Jaiswal SPB, Chitnis DS, Naik G, Artwan KK, Pundit CS, Salgia P, Sepaha A: Prevalence of anti HCV antibodies in central India. Ind J Med Res 1996;104:177-181.
4. Salunkhe PN, Naik SR, Semual SN, Naik S, Kher V: Prevalence of antibodies to hepatitis C virus in HBsAg-negative haemodialysis patients. Ind J Gastroenterol 1992;111:164-165.
5. Agarwal SK, Dash SC, Irshad M: Hepatitis C infection during haemodialysis in India. J Assoc Physicians India 1999;47:1139-1143.
6. Pereira BJ, Levey AS: Hepatitis C virus infection in dialysis and renal transplantation. Kidney Int 1997;51:981-999.
7. Le Pogam S, Le Chapois D, Christen R, Dubois F, Barin F, Goudeau A: Hepatitis C in a haemodialysis unit: molecular evidence for nosocomial transmission. J Clin Microbiol 1998:36:3040-3043.
8. Jadoul M, Poignet JL: Prevention of hepatitis C virus transmission in haemodialysis. Néphrologie 1997;18:307-308.
9. Dos Santos JP, Loureiro A, Cendoroglo Neto M, Pereira BJ: Impact of dialysis room and reuse strategies on the incidence of hepatitis C virus infection in haemodialysis units. Nephrol Dial Transplant 1996;11:2017-2022.
10. Natov SN, Pereira BJ: Hepatitis C in dialysis patients. Adv Ren Replace Ther 1996;3:275-283.
11. Jadoul M: Transmission routes of HCV infection in dialysis. Nephrol Dial Transplant 1996;11(suppl 4):36-38.
12. Beccari M, Romagnoni M, Rizzolo L, Veneroni G, Sorgato G: Is isolation needed for anti-HCV-positive haemodialysis patients? Nephron 1996;72:372.
13. Beccari M: Isolation for anti-HCV-positive haemodialysis patients? Ren Fail 1995;17:775-776.
14. al Meshari K, al Ahdal M, Alfurayh O, Ali A, De Vol E, Kessie G: New insights into hepatitis C virus infection of haemodialysis patients: the implications. Am J Kidney Dis 1995;25:572-578.
15. Fujiyama S, Kawano S, Sato S, Shimada H, Matsushita K, Ikezaki N, Nakano T, Sato T: Changes in prevalence of anti-HCV antibodies associated with preventive measures among haemodialysis patients and dialysis staff. Hepatogastroenterology 1995;42:162-165.
16. Loureiro A, Macedo G, Pinto T: Hepatitis C virus infection in haemodialysis patients: lessons from epidemiology and prophylaxis. Nephrol Dial Transplant 1995;10(suppl 6):83-87.
17. Huraib S, al-Rashed R, Aldrees A, Aljefry M, Arif M, al-Faleh FA: High prevalence of and risk factors for hepatitis C in haemodialysis patients in Saudi Arabia: a need for new dialysis strategies. Nephrol Dial Transplant 1995;10:470-474.
18. Agarwal SK, Dash SC, Mehta SN, Gupta S, Bhowmik D, Tiwari SC, Guleria S: Results of renal transplantation on conventional immunosuppression in second decade in India: a single-centre experience. J Assoc Physicians India 2001;50:532-536.
19. Agarwal SK, Dash SC, Irshad M, Gupta S, Bhwomik D, Tiwari SC, Guleria S, Mehta SN: Impact of hepatitis C viral infection on renal transplant outcome in India: a Single center study. J Assoc Physicians India 2000;48:1155-1159.
20. Agarwal SK, Irshad M, Dash SC: HCV Infection during renal replacement therapy: Should we dialyze all hepatitis-C-positive patients on dedicated machines? Nephron 1998;79:479-480.
21. Agarwal SK, Mohan MP, Varghese M: Assessment of awareness regarding universal precaution among the nursing staff of AIIMS in 1997. J Assoc Physicians India 1998;46:1061.
22. Lemeshow S, Hosmer DW Jr, Klar J, Lwanga SK (eds): Adequacy of Sample Size in Health Studies, ed 1. New York, Wiley, 1991, chapter The Incidence Rate, pp 29-35.
23. Vikrant S, Agarwal SK, Gupta S, Bhowmik D, Tiwari SC, Dash SC, Guleria S, Mehta SN: Prospective randomised control trial of isoniazid chemoprophylaxis during renal replacement therapy. Transplant Infect Dis 2005;7:99-108.
24. Fabrizi F, Poordad FF, Martin P: Hepatitis C infection and the patient with end-stage renal disease. Hepatology 2002;36:3-10.
25. Dussol B, Berthezene P, Brunet P, et al: Hepatitis C virus infection among chronic dialysis patients in the south of France: a collaborative study. Am J Kidney Dis 1995;25:399-404.
26. Hardy NM, Sandroni S, Danielson S, et al: Antibody to hepatitis C virus increases with time on hemodialysis. Clin Nephrol 1992;38:44-48.
27. Seme K, Poljak M, Zuzec-Resek S, et al: Molecular evidence for nosocomial spread of two different hepatitis C virus strains in one hemodialysis unit. Nephron 1997;77:273-278.
28. Stuyver L, Claeys H, Wyseur A, et al: Hepatitis C virus in a hemodialysis unit: molecular evidence for nosocomial transmission. Kidney Int 1996;49:889-895.
29. Centers for Disease Control and Prevention: Recommendations for preventing transmission of infection among chronic hemodialysis patients. MMWR Recommend Rep 2001;50:1-43.
30. Preventing HCV transmission in hemodialysis units. Kidney Int 2008;73(suppl 109):S46-S52; DOI: 10.1038/ki.2008.86.
31. Khaja MN, Madhavi C, Thippavazzula R, Nafeesa F, Habib AM, Habibullah CM, Guntaka RV: High prevalence of hepatitis C virus infection and genotype distribution among general population, blood donors and risk groups. Infect Genet Evol 2006;6:198-204.
32. Reddy AK, Murthy KV, Lakshmi V: Prevalence of HCV infection in patients on haemodialysis: survey by antibody and core antigen detection. Indian J Med Microbiol 2005;23:106-110.
33. Chandra M, Khaja MN, Hussain MM, Poduri CD, Farees N, Habeeb MA, Krishnan S, Ramareddy GV, Habibullah CM: Prevalence of hepatitis B and hepatitis C viral infections in Indian patients with chronic renal failure. Intervirology 2004;47:374-376.
34. Blumberg A, Zehnder C, Burckhardt JJ: Prevention of hepatitis C infection in haemodialysis units: a prospective study. Nephrol Dial Transplant 1995;10:230-233.
35. Djordjevic V, Stojanovic K, Stojanovic M, et al: Prevention of nosocomial transmission of hepatitis C infection in a hemodialysis unit: a prospective study. Int J Artif Organs 2000;23:181-188.
36. Taskapan H, Oymak O, Dogukan A, et al: Patient to patient transmission of hepatitis C virus in hemodialysis units. Clin Nephrol 2001;55:477-481.
37. Harmankaya O, Cetin B, Obek A, Seber E: Low prevalence of hepatitis C virus infection in hemodialysis units: effect of isolation? Ren Fail 2002;24:639-644.
38. Saxena AK, Panhotra BR, Sundaram DS, Naguib M, Venkateshappa CK, Uzzaman W, Mulhim KA: Impact of dedicated space, dialysis equipment, and nursing staff on the transmission of hepatitis C virus in a hemodialysis unit of the Middle East. Am J Infect Control 2003;31:26-33.
39. Yang CS, Chang HH, Chou CC, Peng SJ: Isolation effectively prevents the transmission of hepatitis C virus in the hemodialysis unit. J Formos Med Assoc 2003;102:79-85.
40. Gallego E, López A, Pérez J, Llamas F, Lorenzo I, López E, Illescas ML, Andrés E, Olivas E, Gómez-Roldan C: Effect of isolation measures on the incidence and prevalence of hepatitis C virus infection in hemodialysis. Nephron Clin Pract 2006;104:c1-c6.